Non-Melanoma Skin Cancer Is Now More Deadly Than Melanoma Worldwide

Health & Lifestyle
411

Listen to article (english)

Translate to Spanish or other 102 languages!

Non-melanoma skin cancers accounted for more deaths worldwide than melanoma because they are much more common. Image for illustration purposes
Non-melanoma skin cancers accounted for more deaths worldwide than melanoma because they are much more common. Image for illustration purposes

Medical News Today

- Advertisement -
  • Non-melanoma skin cancers accounted for more deaths worldwide than melanoma because they are much more common.
  • The growing aging population could be one reason skin cancer rates are increasing.
  • Non-melanoma skin cancer is treatable and, in most cases, preventable.

A study being presented at the European Academy of Dermatology and Neurology Congress 2023 reports that there are now more global deaths from non-melanoma skin cancers than melanoma itself.

Follow the link to read the complete article on Medical News Today:

https://www.medicalnewstoday.com/articles/why-non-melanoma-skin-cancer-is-now-more-deadly-than-melanoma-worldwide

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
New Online Tool Allows Women to Quickly Assess Their Risk of Breast & Ovarian Cancer
Next article
October is Fentanyl Poisoning Awareness Month

More Articles

FDA Approves First Factor Xla Inhibitor to Help Prevent Stroke in Certain Adults at High Risk 

The U.S. Food and Drug Administration today approved Sunharbo (asundexian) 50 mg tablets, the first factor XIa (FXIa) inhibitor for use in combination with antiplatelet therapy to reduce the risk of stroke in adults following a recent mild-to-moderate non-cardioembolic ischemic stroke (a stroke caused by a clot that did not originate in the heart) or a high-risk transient ischemic attack (TIA), often called a “mini-stroke.” 

Practical Health Tips to Navigate Cold and Flu Season Safely

With cold and flu season in full swing, experts say there are some simple steps you can take to protect yourself and those around you.

New Therapy for Head and Neck Squamous Cell Carcinoma Receives Accelerated FDA Approval

The U.S. Food and Drug Administration today granted accelerated approval to Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) for the treatment of adults with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) whose disease has progressed on or after platinum-based chemotherapy and immunotherapy.

DHR Health to Host 13th Annual Circle of Care Caregivers Conference

DHR Health Rehabilitation Hospital will host its 13th Annual Circle of Care Caregivers Conference on Saturday, November 7, 2026, at the Edinburg Conference Center at Renaissance, offering educational presentations and resources for individuals caring for family members and loved ones.
- Advertisement -